Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper Rossing

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Diabetes Care|January 5, 2002
Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover studyKasper Rossing, Per K Christensen, Berit R Jensen, et al.
ESC Heart Failure|February 21, 2019
Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcomeTania Deis, Louise Balling, Kasper Rossing, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2002
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathyPeter Jacobsen, Steen Andersen, Kasper Rossing, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 20, 2021
Prognostic value of myocardial flow reserve obtained by 82-rubidium positron emission tomography in long-term follow-up after heart transplantationLærke Marie Nelson, Thomas Emil Christensen, Kasper Rossing, et al.
International Journal of Cardiology|March 12, 2023
Diabetes mellitus and hemodynamics in advanced heart failureBenedicte Heegaard, Tania Deis, Kasper Rossing, et al.
Kidney International|April 5, 2003
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathyPeter Jacobsen, Steen Andersen, Kasper Rossing, et al.
Cardiology|March 27, 2023
Hyponatremia in Stable Patients with Advanced Heart Failure: Association to Hemodynamics and OutcomeKaroline Amalie Rask, Tania Deis, Johan Erik Larsson, et al.
Ugeskrift for Laeger|June 15, 2022
[Myocarditis and development of dilated cardiomyopathy]Christian Bo Poulsen, Kaspar Rene Nielsen, Malene Møller Jørgensen, et al.
Diabetes Care|August 27, 2005
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over studyKasper Rossing, Katrine J Schjoedt, Ulla M Smidt, et al.
Diabetes Care|December 28, 2002
Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over studyKasper Rossing, Per K Christensen, Birgitte V Hansen, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Diabetes Care|January 5, 2002
Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover studyKasper Rossing, Per K Christensen, Berit R Jensen, et al.
ESC Heart Failure|February 21, 2019
Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcomeTania Deis, Louise Balling, Kasper Rossing, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2002
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathyPeter Jacobsen, Steen Andersen, Kasper Rossing, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 20, 2021
Prognostic value of myocardial flow reserve obtained by 82-rubidium positron emission tomography in long-term follow-up after heart transplantationLærke Marie Nelson, Thomas Emil Christensen, Kasper Rossing, et al.
International Journal of Cardiology|March 12, 2023
Diabetes mellitus and hemodynamics in advanced heart failureBenedicte Heegaard, Tania Deis, Kasper Rossing, et al.
Kidney International|April 5, 2003
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathyPeter Jacobsen, Steen Andersen, Kasper Rossing, et al.
Cardiology|March 27, 2023
Hyponatremia in Stable Patients with Advanced Heart Failure: Association to Hemodynamics and OutcomeKaroline Amalie Rask, Tania Deis, Johan Erik Larsson, et al.
Ugeskrift for Laeger|June 15, 2022
[Myocarditis and development of dilated cardiomyopathy]Christian Bo Poulsen, Kaspar Rene Nielsen, Malene Møller Jørgensen, et al.
Diabetes Care|August 27, 2005
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over studyKasper Rossing, Katrine J Schjoedt, Ulla M Smidt, et al.
Diabetes Care|December 28, 2002
Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over studyKasper Rossing, Per K Christensen, Birgitte V Hansen, et al.
Pageof 10